Dutch researchers using preclinical imagers U-SPECT from MILabs of Utrecht, The Netherlands, and Inveon PET from Siemens Healthcare of Knoxville TN, said the imaging methods allowed them to successfully and noninvasively visualize the insulin like growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.
For more information see the Full article at AuntMinnie.com (free registration)